We are live on ! Find out more
Squarepoint

Squarepoint Portfolio holdings

AUM $85.1B
1-Year Est. Return 20.93%
This Fund
S&P 500
This Quarter Est. Return
+17.08%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$13.4B
AUM Growth
+$5.98B
Cap. Flow
+$4.58B
Cap. Flow %
34.18%
Top 10 Hldgs %
24.57%
Holding
3,476
New
1,044
Increased
804
Reduced
979
Closed
616

Top Sells

Rank Stock Value
1
INTU icon
Intuit
INTU
+$51.4M
2
LOW icon
Lowe's Companies
LOW
+$45.3M
3
CVS icon
CVS Health
CVS
+$37.3M
4
LLY icon
Eli Lilly
LLY
+$32.7M
5
SO icon
Southern Company
SO
+$30.6M

Sector Composition

Rank Sector Weight
1 Technology 14.47%
2 Consumer Discretionary 11.59%
3 Healthcare 8.66%
4 Financials 6.8%
5 Industrials 5.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MX icon
2626
Magnachip Semiconductor
MX
$128M
$144K ﹤0.01%
10,623
-8,200
-44% -$113K
FULT icon
2627
Fulton Financial
FULT
$4.7B
$143K ﹤0.01%
+11,281
New +$134K
PUMP icon
2628
ProPetro Holding
PUMP
$1.45B
$143K ﹤0.01%
19,327
-1,812
-9% -$10.1K
MRC
2629
DELISTED
MRC Global
MRC
$142K ﹤0.01%
+21,468
New +$118K
IAG icon
2630
IAMGOLD
IAG
$8.47B
$141K ﹤0.01%
+38,360
New +$141K
CNH
2631
CNH Industrial
CNH
$13.8B
$141K ﹤0.01%
12,637
-15,210
-55% -$132K
NAGE
2632
Niagen Bioscience
NAGE
$256M
$141K ﹤0.01%
29,477
-8,263
-22% -$40.3K
LNSR icon
2633
LENSAR
LNSR
$68.8M
$140K ﹤0.01%
+19,277
New +$165K
LSAK icon
2634
Lesaka Technologies
LSAK
$388M
$140K ﹤0.01%
28,506
+18,038
+172% +$63.1K
COGT icon
2635
Cogent Biosciences
COGT
$6.79B
$138K ﹤0.01%
12,272
-12,067
-50% -$133K
METC icon
2636
Ramaco Resources Class A
METC
$676M
$138K ﹤0.01%
49,615
+34,519
+229% +$105K
TEF
2637
DELISTED
Telefonica
TEF
$138K ﹤0.01%
+38,379
New +$130K
CSPR
2638
DELISTED
Casper Sleep Inc.
CSPR
$138K ﹤0.01%
+22,423
New +$154K
ESXB
2639
DELISTED
Community Bankers Trust Corporation
ESXB
$137K ﹤0.01%
+20,226
New +$124K
LBC
2640
DELISTED
Luther Burbank Corporation Common Stock
LBC
$135K ﹤0.01%
+13,760
New +$135K
BMRA icon
2641
Biomerica
BMRA
$4.88M
$134K ﹤0.01%
3,356
+976
+41% +$48.9K
DHX icon
2642
DHI Group
DHX
$166M
$134K ﹤0.01%
60,146
+3,422
+6% +$7.01K
ESRT icon
2643
Empire State Realty Trust
ESRT
$976M
$134K ﹤0.01%
14,388
+2,804
+24% +$22.1K
ETWO
2644
DELISTED
E2open Parent Holdings
ETWO
$134K ﹤0.01%
+12,344
New +$128K
SB icon
2645
Safe Bulkers
SB
$781M
$134K ﹤0.01%
102,927
+49,491
+93% +$53.2K
PSTX
2646
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$134K ﹤0.01%
12,234
+969
+9% +$10.2K
EGAN icon
2647
eGain
EGAN
$176M
$133K ﹤0.01%
11,235
-7,247
-39% -$102K
TRST
2648
Trustco Bank Corp NY
TRST
$977M
$133K ﹤0.01%
3,997
+756
+23% +$22.8K
UUUU icon
2649
Energy Fuels
UUUU
$2.82B
$133K ﹤0.01%
+31,117
New +$70.1K
XGN icon
2650
Exagen
XGN
$113M
$133K ﹤0.01%
10,078
-7,774
-44% -$110K

Similar funds

Squarepoint's Q4 2020 Portfolio in Review

As of Q4 2020, Squarepoint held 3,476 positions worth $13.4B, up 81% from $7.42B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Squarepoint deployed $4.58B of net new capital in Q4 2020, opening 1,044 new positions and adding to 804 existing holdings. Its largest new stake was iShares Core S&P 500 ETF: 4,102,602 shares worth $1.54B.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Intuit, an estimated $51.4M trimmed.

  • Squarepoint's largest Q4 2020 buy was iShares Core S&P 500 ETF: 4,102,602 shares worth $1.54B.
  • Squarepoint added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $437M increase.
  • Squarepoint's biggest Q4 2020 reduction was Intuit, cutting an estimated $51.4M.
  • Squarepoint fully exited iShares Biotechnology ETF in Q4 2020, selling an estimated $29.3M.
  • Squarepoint's ten largest holdings make up 25% of its $13.4B portfolio in Q4 2020.
  • Squarepoint opened 1,044 new positions and closed 616 in Q4 2020.
  • Squarepoint's portfolio value rose 81% quarter-over-quarter to $13.4B.

Based on Squarepoint's 13F filing for Q4 2020, filed 16 Feb 2021.